AARDEX Group

Nature Reviews on Drug Discovery

anticoagulation
FEB-2017 : Nature Reviews on Drug Discovery features adherence-informed

FEB-2017 : Nature Reviews on Drug Discovery features adherence-informed clinical trials using reliable measurements, like the MEMS®, to optimize drug development.

Nature Reviews on Drug Discovery features adherence-informed clinical trials using reliable measurements, like the MEMS®, to optimize drug development.

Poor adherence in clinical trials reduces their value by altering estimates of benefits and harms, and wasting time, money and patient experience. Methods for measuring and encouraging adherence are essential components of clinical trials and every effort should be made to incorporate adherence measures in phase II and phase III trials in order to avoid important errors in interpreting benefits and harms.

The paper will be presented and discussed at the Pharmaceutical Sciences World Congress in Stockholm, Sweden, 21-24 May 2017.

Share This Post

You may also like...

Outsourcing in Clinical Trials Europe (1)
Breaking News

Meet us at Outsourcing in Clinical Trials Europe 2023

Exciting news! AARDEX Group is gearing up for one of the most highly anticipated events in the clinical trials industry – the 13th Annual Outsourcing in Clinical Trials Europe conference, which will take place in the beautiful city of Barcelona